Lv12
38 积分 2025-09-02 加入
Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US
1天前
待确认
Projecting overall survival in health-economic models: uncertainty and maturity of data
2个月前
已完结
皖公网安备34019202002308
